DHC SEC Filings - Diversified Healthcare Tr 10-K, 10-Q, 8-K Forms
This page serves as a comprehensive resource for investors to access SEC filings for Diversified Healthcare Trust (DHC), including annual (10-K), quarterly (10-Q), and material event (8-K) reports, as well as insider trading forms. It highlights DHC's financial condition, portfolio of senior living, medical office, and life science properties, and capital structure through these regulatory documents. The article also details recent filings, such as investor presentations, the execution of secured notes, and insider share transactions for tax withholding and equity awards.
Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th
Diversified Healthcare Trust (DHC) announced that its first-quarter 2026 financial results will be released after the Nasdaq closes on Monday, May 4, 2026. Following this, a conference call will be held on Tuesday, May 5, 2026, at 10:00 a.m. Eastern Time to discuss the results, featuring the President and CEO Christopher Bilotto and other executives. A replay of the call and a live audio webcast will also be available for those unable to attend live.
Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th
Diversified Healthcare Trust (DHC) announced its first quarter 2026 financial results will be released after the Nasdaq closes on Monday, May 4, 2026. A conference call to discuss these results will be held on Tuesday, May 5, 2026, at 10:00 a.m. Eastern Time, hosted by President and CEO Christopher Bilotto, CFO Matthew Brown, and VP Anthony Paula. The call details, including dial-in numbers and webcast information, are provided for interested participants and a replay will be available until May 12, 2026.
Tangible book value per share of Diversified Healthcare Trust – SWB:SNF
This article provides financial information for Diversified Healthcare Trust (SWB:SNF), specifically focusing on its tangible book value per share. It presents a table with period, value, and change data for this metric. The article is sourced from TradingView and indicates that market data is provided by ICE Data Services and reference data by FactSet.
Short Interest in Diversified Healthcare Trust (NASDAQ:DHC) Grows By 20.6%
Short interest in Diversified Healthcare Trust (NASDAQ:DHC) rose by 20.6% in March, reaching 7,519,124 shares, representing about 3.5% of the stock with a 3.0 days-to-cover ratio. Major institutions, including Goldman Sachs, significantly increased their holdings, bringing institutional ownership to approximately 75.98%. Analysts currently have a "Hold" consensus on the stock with an average price target of $7.25, amidst recent quarterly earnings that missed expectations and a minimal annualized dividend payout.
How Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) Affects Rotational Strategy Timing
This article analyzes Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL), identifying weak near and mid-term sentiment but a strong long-term outlook. It provides AI-generated trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels. The report emphasizes elevated downside risk due to a lack of additional long-term support signals.
Analyst Sentiment Shifts as Diversified Healthcare Trust Shares Rally
Diversified Healthcare Trust (DHC) shares have rallied significantly this year, driven by stronger-than-expected Q4 2025 earnings. Market observers have responded by raising price targets, with the average climbing from $4.50 to $7.25, indicating growing optimism. The focus for investors now shifts to the upcoming May 2026 earnings report, as continued operational improvements, especially in reducing vacancy rates, are crucial for sustaining this positive trend and meeting the new price targets.
Diversified Healthcare Trust (DHC) price target increased by 26.09% to 7.40
The price target for Diversified Healthcare Trust (DHC) has been increased by 26.09% to $7.40. This adjustment reflects a significant positive change in analyst expectations for the company's valuation.
Vanguard reports 0% stake in Diversified Healthcare Trust (DHC)
Vanguard has filed an Amendment No. 2 on Schedule 13G/A, reporting a 0% stake in Diversified Healthcare Trust (DHC), with 0 shares beneficially owned. This change is attributed to an internal realignment on January 12, 2026, which disaggregated reporting of beneficial ownership among Vanguard's subsidiaries and business divisions. The filing clarifies that this is a reporting structure change, not an economic transfer or sale of securities.
Debt repayment, 113% 2025 return shape Diversified Healthcare Trust (NASDAQ: DHC) 2026 proxy
Diversified Healthcare Trust (DHC) highlighted strong 2025 performance in its 2026 proxy statement, showcasing the sale of 69 non-core properties for $605 million which enabled full repayment of 2026 zero coupon senior secured notes, eliminating debt maturities until 2028. The company also transitioned 116 senior housing operating communities to new managers and reported being the top-performing U.S. REIT in 2025 with a 113% total shareholder return. DHC is asking shareholders to vote on electing seven trustees, approving executive compensation on an advisory basis, and ratifying Deloitte & Touche as auditor at its virtual annual meeting on June 10, 2026.
[ARS] DIVERSIFIED HEALTHCARE TRUST SEC Filing
This article announces an SEC ARS filing by Diversified Healthcare Trust (DHC) on March 19, 2026, at 04:10 PM. The filing is available as a PDF document on SEC EDGAR. The article also provides recent news and SEC filings for DHC, along with key stock data.
Discipline and Rules-Based Execution in DHCNI Response
This article provides an in-depth analysis of Diversified Healthcare Trust 5.625% Senior Notes Due 2042 (NASDAQ: DHCNI) using AI models. It highlights neutral near and mid-term readings that could moderate a long-term positive bias, noting resistance testing and an exceptional risk-reward short setup. The piece outlines distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for varying risk profiles, along with multi-timeframe signal analysis.
165,300 Shares in Diversified Healthcare Trust $DHC Purchased by Militia Capital Partners LP
Militia Capital Partners LP recently acquired 165,300 shares of Diversified Healthcare Trust (DHC) for approximately $729,000, representing 0.07% of the company. Institutional investors collectively own about 75.98% of DHC. Despite missing EPS and revenue estimates in its last quarterly report, analysts have a mixed "Hold" rating with an average target price of $7.25, while B. Riley Financial recently raised its target to $8.50.
Diversified Healthcare Trust $DHC Shares Bought by Carronade Capital Management LP
Carronade Capital Management LP significantly increased its stake in Diversified Healthcare Trust (DHC) during Q3, adding 2,943,300 shares to hold over 4.5 million shares, making it their 13th largest holding. Concurrently, DHC's CEO, Christopher J. Bilotto, also boosted his personal holdings by purchasing 20,000 shares. Despite this increased institutional and insider investment, Diversified Healthcare Trust missed its Q3 earnings expectations.
2026 Guidance on Balance Sheet Repair and Senior Housing NOI Could Be A Game Changer For Diversified Healthcare Trust (DHC)
Diversified Healthcare Trust (DHC) recently reported Q4 and full-year 2025 results, showing ongoing net losses but improved revenue figures. Their 2026 guidance, which focuses on continued balance sheet repair, NOI growth in senior housing, and lower interest costs, has attracted significant analyst and investor interest. This guidance is seen as pivotal for reshaping DHC's investment narrative, with management expecting operational improvements and debt reduction to support equity over the next few years, despite current high leverage and refinancing risks.
2026 Guidance on Balance Sheet Repair and Senior Housing NOI Could Be A Game Changer For Diversified Healthcare Trust (DHC)
Diversified Healthcare Trust (DHC) recently released its Q4 and full-year 2025 results, showing a reduced net loss, and revenue of US$1.54 billion. The company's 2026 guidance, which includes ongoing balance sheet repair, senior housing NOI growth, and lower interest costs, has garnered significant attention from analysts and investors, potentially reshaping its investment narrative. While the guidance offers a clearer view of operational improvement, investors should remain aware of refinancing risks associated with high leverage.
Diversified Healthcare Trust closes mortgage financing through Freddie Mac to redeem outstanding notes
Diversified Healthcare Trust (DHC) announced the closing of a secured mortgage financing through Freddie Mac for five of its senior living communities. This financing, totaling $100 million, will be used to redeem all outstanding 6.25% senior notes due 2026, improving the company's financial flexibility.
Analysts Offer Insights on Real Estate Companies: Diversified Healthcare Trust (DHC), Cubesmart (CUBE) and SBA Communications (SBAC)
RBC Capital analysts provided insights on several real estate companies. Michael Carroll maintained a Hold rating for Diversified Healthcare Trust (DHC) with a $6.00 price target, while Brad Heffern gave Cubesmart (CUBE) a Buy rating with a target of $46.00. Jonathan Atkin also maintained a Buy rating for SBA Communications (SBAC), setting a price target of $220.00.
DHCNI Stock Price, News & Analysis
This article provides an overview of Diversified Healthcare Tr (DHCNI), including its stock performance, financial highlights, and SEC filings. It notes that there is no recent news available, but details recent SEC filings and offers financial metrics such as revenue, net income, and EPS. The short interest data indicates low bearish sentiment, and a balanced liquidity scenario for short positions.
Diversified Healthcare Trust (NASDAQ:DHC) Given New $8.50 Price Target at B. Riley Financial
B. Riley Financial has increased its price target for Diversified Healthcare Trust (NASDAQ:DHC) from $6.50 to $8.50, maintaining a "buy" rating, despite the company missing its recent quarterly EPS and revenue estimates. Investors and insiders show significant holdings, with CEO Christopher Bilotto recently purchasing 20,000 shares. The company, a REIT specializing in healthcare properties, is facing profitability pressures but is attracting institutional investment.
Diversified Healthcare Trust price target raised to $8.50 from $6.50 at B. Riley
B. Riley analyst John Massocca has increased the price target for Diversified Healthcare Trust (DHC) to $8.50 from $6.50, reiterating a Buy rating. The upgrade is based on the company's 2026 outlook which suggests "value growth potential," and the firm believes the stock's current discount compared to its peers is "too severe."
A Look At Diversified Healthcare Trust (DHC) Valuation After Earnings Reveal Narrower Net Loss
Diversified Healthcare Trust (DHC) recently reported Q4 and full-year 2025 results, showing reduced quarterly sales but a narrower net loss, which has drawn investor attention. Despite a significant share price rebound over the last year, the stock is considered "Overvalued" with a fair value of $5.75 against a current price of $6.76. This valuation hinges on future profitability, cash flow, and the company's strategy of repositioning its portfolio towards high-growth healthcare properties.
A Look At Diversified Healthcare Trust (DHC) Valuation After Earnings Reveal Narrower Net Loss
Diversified Healthcare Trust (DHC) recently reported Q4 and full-year 2025 results, showing lower quarterly sales but a narrower net loss, attracting investor attention. Despite a significant share price run-up, the company's valuation of $6.76 is considered overvalued compared to a fair value of $5.75, based on current financial narratives and future profitability expectations. The article suggests investors review underlying data and consider risk factors like high leverage and asset sales before making investment decisions.
RBC Raises Price Target on Diversified Healthcare Trust to $6 From $5, Keeps Sector Perform Rating
RBC has increased its price target for Diversified Healthcare Trust (DHC) to $6, up from $5, while maintaining a "Sector Perform" rating on the stock. This adjustment comes as the company continues to release earnings and business updates. Diversified Healthcare Trust is a real estate investment trust specializing in medical office, life science properties, and senior living communities.
A Look At Diversified Healthcare Trust (DHC) Valuation After Earnings Reveal Narrower Net Loss
Diversified Healthcare Trust (DHC) recently reported fourth-quarter and full-year 2025 earnings, showing reduced quarterly sales but a narrower net loss, which has drawn investor attention. Despite a significant stock rally and the current share price of US$6.76 exceeding the fair value of US$5.75, the market appears to be pricing in future growth, driven by active portfolio repositioning and a focus on high-growth healthcare properties. However, analysts caution about potential risks from high leverage meeting rising interest costs or if asset sales negatively impact future rental income.
Healthcare trust posts Q4 2025 results, issues 2026 financial guidance
Diversified Healthcare Trust (DHC) announced its financial results for the fourth quarter ended December 31, 2025, and provided full-year 2026 financial guidance. The company will host a conference call on February 24, 2026, to discuss these results. DHC, a real estate investment trust, owns a portfolio of healthcare properties across the United States.
DHCNL Financials: Income Statement, Balance Sheet & Cash Flow
This article provides a comprehensive overview of Diversified Healthcare Trust (DHCNL)'s financial statements, including income statement, balance sheet, and cash flow for fiscal year 2025 and prior periods. It details key financial metrics such as revenue ($1.5B), net income (-$285.9M), and EPS ($-1.19), highlighting changes from previous years. The analysis also covers financial health signals like a neutral Piotroski F-Score and low earnings quality, indicating areas for potential investor concern.
The Bull Case For Diversified Healthcare Trust (DHC) Could Change Following 2025 Results And Balance Sheet Reset
Diversified Healthcare Trust (DHC) reported its Q4 and full-year 2025 results, showing narrowed net losses and positive funds from operations, along with significant capital markets activity and no debt maturities until 2028. The company achieved 31.3% consolidated net operating income growth in 2025, primarily from its Senior Housing Operating Portfolio. This progress could lead analysts to revise their cautious outlook on DHC's future performance.
The Bull Case For Diversified Healthcare Trust (DHC) Could Change Following 2025 Results And Balance Sheet Reset
Diversified Healthcare Trust (DHC) reported its Q4 and full-year 2025 results, showing a narrowed net loss of US$285.89 million and positive funds from operations. The company achieved 31.3% consolidated net operating income growth, completed US$1.40 billion in capital market activities, and has no debt maturities until 2028, significantly reshaping its financial position. This progress, especially in the senior housing portfolio, could lead analysts to reconsider their cautious outlook on DHC's future cash flows.
Diversified Healthcare Trust ‘Substantially Done’ With SHOP Sales, Plans to Reinvest in Portfolio
Diversified Healthcare Trust (DHC) has largely completed its community sales, offloading 69 properties in 2025 and an additional 37 subsequent to the fourth quarter for total proceeds exceeding $850 million. The company plans to reinvest these funds into its remaining 212 senior housing operating portfolio (SHOP) properties, focusing on occupancy growth, revenue increases, and repositioning underutilized spaces to add new units. DHC reported a fourth-quarter 2025 loss of $21.2 million but saw NOI for its SHOP segment exceed $139 million, driven by occupancy gains and rate increases.
Diversified Healthcare Trust (NASDAQ:DHC) Q4 2025 Earnings Call Transcript
Diversified Healthcare Trust (NASDAQ: DHC) reported strong fourth-quarter 2025 results, with SHOP NOI improving 27.6% over the prior year due to effective execution of strategic initiatives. The company completed over $1.4 billion in capital markets activity and transitioned 116 communities to new operators, leading to significant leverage reduction and no debt maturities until 2028. DHC also provided optimistic 2026 guidance, expecting continued growth in its senior housing operating portfolio (SHOP) and Medical Office and Life Sciences segments.
Diversified Healthcare Trust Highlights Strong 2025 Performance Outlook
Diversified Healthcare Trust (DHC) released an investor presentation highlighting its strong performance in 2025, including a 113% total shareholder return. The company, a national healthcare REIT, manages a $6.3 billion portfolio focused on senior housing, medical offices, and life science assets. Despite a "Hold" rating from analysts and some financial weaknesses noted by TipRanks' AI Analyst Spark, DHC emphasizes its diversified asset mix and demographic tailwinds for future growth.
DHC (DHC) Revenue Holds Near US$380 Million As Losses Reinforce Bearish Narratives
Diversified Healthcare Trust (DHC) reported Q4 2025 revenue of US$379.6 million and a basic EPS loss of US$0.09, with trailing twelve-month revenue around US$1.5 billion and a basic EPS loss of US$1.19. Despite revenue holding steady, the company continues to report net income losses, which strengthens the bearish argument that current revenue levels are insufficient to offset costs. The stock trades at a low P/S multiple but its DCF fair value is significantly below its current share price, indicating a mixed valuation picture.
DIVERSIFIED HEALTHCARE TRUST SEC 10-K Report
Diversified Healthcare Trust (DHC) has released its annual 10-K report detailing financial performance, business operations, and strategic initiatives. The report highlights increased revenues and reduced net loss, driven by strong performance in its senior living communities (SHOP segment). DHC faces challenges including market risks from commercial real estate conditions, operational risks due to reliance on third-party managers, regulatory hurdles, and rising labor costs.
Is It Too Late To Consider Diversified Healthcare Trust (DHC) After Its 1 Year Surge?
Diversified Healthcare Trust (DHC) has seen a significant 158.1% gain over the last year, but its current valuation suggests it might be overvalued. A Discounted Cash Flow (DCF) analysis estimates its intrinsic value at $0.99 per share, indicating it's very expensive compared to its recent closing price of US$6.15. While its Price-to-Sales (P/S) ratio is below industry averages, Simply Wall St's proprietary "Fair Ratio" still suggests it's slightly expensive, leading to a mixed valuation score.
Diversified Healthcare: Q4 Earnings Snapshot
Diversified Healthcare Trust (DHC) reported its fourth-quarter financial results, including funds from operations of $21.8 million, or 9 cents per share. The real estate investment trust also announced a net loss of $21.2 million and total revenue of $379.6 million for the quarter. For the full year, DHC reported funds from operations of $64.4 million and revenue of $1.54 billion.
DIVERSIFIED HEALTHCARE TRUST ($DHC) Releases Q4 2025 Earnings
Diversified Healthcare Trust ($DHC) reported its Q4 2025 earnings, with earnings per share of $0.09, significantly beating analyst estimates of -$0.18. However, the company's revenue of $379,570,000 missed estimates of $396,817,556. The article also details recent hedge fund activity, with some major institutions decreasing their positions, and mentions analyst ratings and price targets for DHC stock.
Diversified Healthcare: Q4 Earnings Snapshot
Diversified Healthcare Trust (DHC) reported funds from operations of $21.8 million, or 9 cents per share, for its fourth quarter, alongside a net loss of $2.2 million or 9 cents per share. The real estate investment trust posted revenues of $376.5 million for the quarter and $1.66 billion for the full year. This financial data was generated by Automated Insights using information from Zacks Investment Research.
Diversified Healthcare Trust releases latest performance outlook, expects total revenue (REV) for fiscal year 2026 to grow by approximately 8.0%
Diversified Healthcare Trust anticipates an approximate 8.0% growth in total revenue for fiscal year 2026, alongside a 5.3% increase in the average monthly rate of its properties. This positive outlook highlights the company's strong operational performance and ongoing expansion within the healthcare real estate sector. The growth is indicative of the company's robust position in the market.
Diversified Healthcare Trust Announces Fourth Quarter 2025 Results
Diversified Healthcare Trust (Nasdaq: DHC) has released its financial results for the fourth quarter ended December 31, 2025, and provided full-year 2026 financial guidance. The company will host a conference call on February 24, 2026, to discuss these results, which are available on its website. DHC focuses on owning high-quality healthcare properties across the United States, with a portfolio valued at approximately $6.3 billion as of December 31, 2025.
Diversified Healthcare Trust Announces Fourth Quarter 2025 Results
Diversified Healthcare Trust (DHC) announced its financial results for the quarter ended December 31, 2025, and provided its full year 2026 financial guidance. A conference call is scheduled for February 24, 2026, to discuss these results. DHC is a real estate investment trust specializing in high-quality healthcare properties across the United States.
Diversified Healthcare: Q4 Earnings Snapshot
Diversified Healthcare Trust (DHC) reported its fourth-quarter and full-year financial results. The real estate investment trust announced funds from operations of $21.8 million, or 9 cents per share, for Q4, and a net loss of $21.2 million. Annual funds from operations totaled $64.4 million, with revenue reaching $1.54 billion.
Diversified Healthcare Trust (DHC) to Release Quarterly Earnings on Monday
Diversified Healthcare Trust (DHC) is set to release its Q4 2025 earnings after market close on Monday, February 23rd, with analysts forecasting EPS of $0.12 and revenue of $392.889 million. The company's stock opened at $6.55, has a market cap of $1.59 billion, and a negative P/E ratio, reflecting recent losses. Analyst sentiment is mixed, with a "Reduce" consensus, while CEO Christopher Bilotto recently increased his insider holdings.
DHC stock hits 52-week high at 6.54 USD
Diversified Healthcare Trust (DHC) stock reached a new 52-week high at $6.54, reflecting a 130.9% increase over the past year and significant momentum. Despite appearing overvalued according to InvestingPro data, the company has maintained dividend payments for 28 consecutive years and benefits from strategic initiatives and favorable market conditions in healthcare real estate. Recent financial activities include the sale of non-core properties and an upgrade from RBC Capital, highlighting a period of robust growth and positive investor outlook.
The Technical Signals Behind (DHCNL) That Institutions Follow
This article analyzes the technical signals for Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (NASDAQ: DHCNL), noting neutral near and mid-term readings that could moderate a long-term positive bias. It identifies resistance testing and outlines institutional trading strategies, including long, momentum breakout, and short positions, along with multi-timeframe signal analysis. The piece also highlights the AI-generated signals and various features offered to subscribers for real-time analysis and risk management.
Diversified Healthcare Trust (NASDAQ:DHC) Sets New 52-Week High - Here's What Happened
Diversified Healthcare Trust (NASDAQ:DHC) recently hit a new 52-week high of $6.54, trading at $6.42 with 1.24 million shares exchanged. The company has a "Reduce" average analyst rating with a $5.75 target price, noting mixed analyst opinions from "strong sell" to "buy." CEO Christopher Bilotto recently increased his stake, and the company declared a $0.01 quarterly dividend.
Diversified Healthcare Trust Bolsters Financial Position with Strategic Moves
Diversified Healthcare Trust (DHC) has reached a new annual peak in its stock price, driven by strategic portfolio restructuring and significant debt reduction. The company fully redeemed its 2026 secured zero-coupon notes and generated approximately $605 million from property sales in 2025, eliminating major debt maturities until 2028. Investors are now anticipating the release of DHC's fourth-quarter 2025 financial results on February 23rd, followed by an analyst conference call to discuss future strategies.
Precision Trading with Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) Risk Zones
This article provides a precision trading analysis for Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL), highlighting a strong overweight bias across all horizons. It identifies an exceptional 22.6:1 risk-reward setup targeting a 6.1% gain versus 0.3% risk. The analysis includes institutional trading strategies tailored for different risk profiles, featuring position, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis.
Diversified Healthcare Trust $DHC Shares Purchased by SG Americas Securities LLC
SG Americas Securities LLC significantly increased its stake in Diversified Healthcare Trust (DHC) by 560.3% in Q3, now owning 244,211 shares valued at $1.08 million. This comes as DHC's CEO also purchased an additional 20,000 shares, increasing his personal holdings. Despite missing Q3 EPS estimates, the company's revenue beat expectations, and the stock is trading near its one-year high, with analysts maintaining a "Hold" consensus rating.
Does AlerisLife Cash and Portfolio Shift Change The Bull Case For Diversified Healthcare Trust (DHC)?
Diversified Healthcare Trust (DHC) recently received a significant cash infusion from AlerisLife's asset sale and wind-down, alongside ongoing non-core property sales, as part of its strategy to reshape its senior housing portfolio and improve financial flexibility. While these actions support near-term liquidity and de-risking efforts, the company remains unprofitable and highly leveraged, with refinancing risk being a key concern. Investors are closely watching if these portfolio changes will lead to more sustainable earnings and distributions, though there's a wide range of fair value estimates for the stock.
